Sunday, 31 May 2009

Card-OK




Card-OK may be available in the countries listed below.


Ingredient matches for Card-OK



Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Card-OK in the following countries:


  • Greece

International Drug Name Search

Wednesday, 27 May 2009

Mannitolo + Sodio Cloruro Galenica




Mannitolo + Sodio Cloruro Galenica may be available in the countries listed below.


Ingredient matches for Mannitolo + Sodio Cloruro Galenica



Mannitol

Mannitol is reported as an ingredient of Mannitolo + Sodio Cloruro Galenica in the following countries:


  • Italy

International Drug Name Search

Tuesday, 26 May 2009

Methacycline




Methacycline may be available in the countries listed below.


Ingredient matches for Methacycline



Metacycline

Methacycline (BAN, USAN) is also known as Metacycline (Prop.INN)

International Drug Name Search

Glossary

BANBritish Approved Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 21 May 2009

N.F.S.




N.F.S. may be available in the countries listed below.


Ingredient matches for N.F.S.



Norfloxacin

Norfloxacin is reported as an ingredient of N.F.S. in the following countries:


  • Taiwan

International Drug Name Search

Wednesday, 20 May 2009

Pritaren




Pritaren may be available in the countries listed below.


Ingredient matches for Pritaren



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Pritaren in the following countries:


  • Singapore

International Drug Name Search

Friday, 15 May 2009

Omnicef




In the US, Omnicef (cefdinir systemic) is a member of the drug class third generation cephalosporins and is used to treat Bronchitis, Otitis Media, Pneumonia, Sinusitis, Skin and Structure Infection, Skin Infection and Tonsillitis/Pharyngitis.

US matches:

  • Omnicef

  • Omnicef Suspension

  • Omnicef Omni-Pac

Ingredient matches for Omnicef



Cefdinir

Cefdinir is reported as an ingredient of Omnicef in the following countries:


  • Bahrain

  • Egypt

  • Indonesia

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Mexico

  • Myanmar

  • Oman

  • Qatar

  • Saudi Arabia

  • Sudan

  • Syria

  • Thailand

  • United Arab Emirates

  • United States

  • Vietnam

  • Yemen

International Drug Name Search

Tuesday, 12 May 2009

Veragamma




Veragamma may be available in the countries listed below.


Ingredient matches for Veragamma



Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Veragamma in the following countries:


  • Germany

International Drug Name Search

Tuesday, 5 May 2009

Suldox




Suldox may be available in the countries listed below.


Ingredient matches for Suldox



Pyrimethamine

Pyrimethamine is reported as an ingredient of Suldox in the following countries:


  • Indonesia

Sulfadoxine

Sulfadoxine is reported as an ingredient of Suldox in the following countries:


  • Indonesia

International Drug Name Search

Monday, 4 May 2009

Izosorbid




Izosorbid may be available in the countries listed below.


Ingredient matches for Izosorbid



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Izosorbid in the following countries:


  • Croatia (Hrvatska)

International Drug Name Search

Friday, 1 May 2009

Duragesic-100


See also: Generic Duragesic-12, Generic Duragesic-25, Generic Duragesic-50, Generic Duragesic-75


Duragesic-100 is a brand name of fentanyl, approved by the FDA in the following formulation(s):


DURAGESIC-100 (fentanyl - film, extended release; transdermal)



  • Manufacturer: JANSSEN PHARMS

    Approval date: August 7, 1990

    Strength(s): 100MCG/HR [AB]

Has a generic version of Duragesic-100 been approved?


Yes. The following products are equivalent to Duragesic-100:


FENTANYL-100 (fentanyl film, extended release; transdermal)



  • Manufacturer: ACTAVIS

    Approval date: August 20, 2007

    Strength(s): 100MCG/HR [AB]


  • Manufacturer: LAVIPHARM LABS

    Approval date: August 4, 2006

    Strength(s): 100MCG/HR [AB]


  • Manufacturer: MALLINCKRODT INC

    Approval date: February 9, 2011

    Strength(s): 100MCG/HR [AB]


  • Manufacturer: MYLAN TECHNOLOGIES

    Approval date: January 28, 2005

    Strength(s): 100MCG/HR [AB]


  • Manufacturer: NOVEN

    Approval date: October 16, 2009

    Strength(s): 100MCG/HR [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: October 20, 2008

    Strength(s): 100MCG/HR [AB]


  • Manufacturer: WATSON LABS

    Approval date: August 20, 2007

    Strength(s): 100MCG/HR [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Duragesic-100. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Duragesic-100.

See also...

  • Duragesic-100 skin patch Consumer Information (Cerner Multum)
  • Fentanyl Consumer Information (Drugs.com)
  • Fentanyl Consumer Information (Wolters Kluwer)
  • Fentanyl Lozenge Consumer Information (Wolters Kluwer)
  • Fentanyl Patch Consumer Information (Wolters Kluwer)
  • Fentanyl Soluble Film Consumer Information (Wolters Kluwer)
  • Fentanyl Spray Consumer Information (Wolters Kluwer)
  • Fentanyl Tablet Consumer Information (Wolters Kluwer)
  • Fentanyl buccal Consumer Information (Cerner Multum)
  • Fentanyl citrate oral transmucosal Consumer Information (Cerner Multum)
  • Fentanyl nasal Consumer Information (Cerner Multum)
  • Fentanyl sublingual Consumer Information (Cerner Multum)
  • Fentanyl transdermal device Consumer Information (Cerner Multum)
  • Fentanyl transdermal skin patch Consumer Information (Cerner Multum)
  • Fentanyl Buccal mucosa, Oromucosal Advanced Consumer Information (Micromedex)
  • Fentanyl Nasal Advanced Consumer Information (Micromedex)
  • Fentanyl Transdermal Advanced Consumer Information (Micromedex)
  • Fentanyl Citrate AHFS DI Monographs (ASHP)